+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiopharmaceuticals Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5228424
  • Report
  • December 2020
  • Region: Global
  • 200 pages
  • The Business Research Company

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Areva Pharma
  • Bracco Imaging S.p.A.
  • Curium
  • Eckert & Ziegler
  • GE Healthcare
  • Mallinckrodt plc
Radiopharmaceuticals Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global radiopharmaceuticals market.

This report focuses on radiopharmaceuticals market which is experiencing strong growth. The report gives a guide to the radiopharmaceuticals market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the radiopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Radiopharmaceuticals market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider radiopharmaceuticals market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The radiopharmaceuticals market section of the report gives context. It compares the radiopharmaceuticals market with other segments of the radiopharmaceuticals market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, radiopharmaceuticals indicators comparison.
Scope

Markets Covered:
1) By Type: Diagnostic; Therapeutic; Others
2) By Application: Oncology; Cardiology; Gastroenterology; Neuroendocrinnology; Neurology; Nephrology; Others
3) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Cancer Research Institutes; Others

Companies Mentioned: Siemens Healthcare Private Limited; Bayer; GE Healthcare; Novartis AG; Cardinal Health

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Areva Pharma
  • Bracco Imaging S.p.A.
  • Curium
  • Eckert & Ziegler
  • GE Healthcare
  • Mallinckrodt plc
1. Executive Summary

2. Radiopharmaceuticals Market Characteristics

3. Radiopharmaceuticals Market Size And Growth
3.1. Global Radiopharmaceuticals Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Radiopharmaceuticals Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Radiopharmaceuticals Market Segmentation
4.1. Global Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Diagnostic
  • Therapeutic
  • Others
4.2. Global Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oncology
  • Cardiology
  • Gastroenterology
  • Neuroendocrinnology
  • Neurology
  • Nephrology
  • Others
4.3. Global Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cancer Research Institutes
  • Others
5. Radiopharmaceuticals Market Regional And Country Analysis
5.1. Global Radiopharmaceuticals Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Radiopharmaceuticals Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Radiopharmaceuticals Market
6.1. Asia-Pacific Radiopharmaceuticals Market Overview
6.2. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Radiopharmaceuticals Market
7.1. China Radiopharmaceuticals Market Overview
7.2. China Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Radiopharmaceuticals Market
8.1. India Radiopharmaceuticals Market Overview
8.2. India Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Radiopharmaceuticals Market
9.1. Japan Radiopharmaceuticals Market Overview
9.2. Japan Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Radiopharmaceuticals Market
10.1. Australia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Radiopharmaceuticals Market
11.1. Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Radiopharmaceuticals Market
12.1. South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Radiopharmaceuticals Market
13.1. Western Europe Radiopharmaceuticals Market Overview
13.2. Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Radiopharmaceuticals Market
14.1. UK Radiopharmaceuticals Market Overview
14.2. UK Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Radiopharmaceuticals Market
15.1. Germany Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Radiopharmaceuticals Market
16.4. France Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Radiopharmaceuticals Market
17.1. Eastern Europe Radiopharmaceuticals Market Overview
17.2. Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Radiopharmaceuticals Market
18.1. Russia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Radiopharmaceuticals Market
19.1. North America Radiopharmaceuticals Market Overview
19.2. North America Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Radiopharmaceuticals Market
20.1. USA Radiopharmaceuticals Market Overview
20.2. USA Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Radiopharmaceuticals Market
21.1. South America Radiopharmaceuticals Market Overview
21.2. South America Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Radiopharmaceuticals Market
22.1. Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Radiopharmaceuticals Market
23.1. Middle East Radiopharmaceuticals Market Overview
23.2. Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Radiopharmaceuticals Market
24.1. Africa Radiopharmaceuticals Market Overview
24.2. Africa Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Radiopharmaceuticals Market Competitive Landscape And Company Profiles
25.1. Radiopharmaceuticals Market Competitive Landscape
25.2. Radiopharmaceuticals Market Company Profiles
25.2.1. Siemens Healthcare Private Limited
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Bayer
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. GE Healthcare
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Novartis AG
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Cardinal Health
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Radiopharmaceuticals Market

27. Radiopharmaceuticals Market Trends And Strategies

28. Radiopharmaceuticals Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Areva Pharma
  • Bracco Imaging S.p.A.
  • Curium
  • Eckert & Ziegler
  • GE Healthcare
  • Mallinckrodt plc
Major players in the radiopharmaceuticals market are Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A., Nordion, Inc. (A Subsidiary of Sterigenics International), Mallinckrodt plc and Curium.

The global radiopharmaceuticals market is expected to decline from $5.07 billion in 2019 to $4.78 billion in 2020 at a compound annual growth rate (CAGR) of -5.72%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $5.88 billion in 2023 at a CAGR of 7.13%.

The radiopharmaceuticals market consists of sales of radiopharmaceuticals and related services by entities (organizations, sole traders, and partnerships) that produce radiopharmaceuticals used in treating cancer, cardiovascular, and other diseases. Radiopharmaceuticals are radioactive compounds administered to the patients, monitored via specific imaging devices, and used for diagnostic and therapeutic purposes.

North America was the largest region in the radiopharmaceuticals market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

In December 2019, Curium, a nuclear medicine solution provider, completed the acquisition of MAP Medical Technologies Oy, a Finnish radiopharmaceutical company, for an undisclosed amount. The acquisition is expected to expand the geographical footprint of Curium in Europe along with the product portfolio expansion. Medical Technologies Oy is a Finnish company founded in 1991 and develops and manufactures radiopharmaceuticals. The products of the company are developed to meet the needs of nuclear medicine professionals.

The radiopharmaceuticals market covered in this report is segmented by type into diagnostic; therapeutic; others. It is also segmented by application into oncology; cardiology; gastroenterology; neuroendocrinology; neurology; nephrology; others and by end user into hospitals; ambulatory surgical centers; diagnostic centers; cancer research institutes; others.

The high cost of radiopharmaceuticals is anticipated to limit the growth of the market. High costs and short half-life of radiopharmaceuticals are reducing their implementation in hospitals and clinics. The development cost of radiopharmaceuticals is very high compared to that of therapeutic drugs and also undergoes a very lengthy and expensive regulatory process. For instance, the cost of diagnostic radiopharmaceuticals development is $100 to $200 million for 8-10 years in comparison with the cost of pharmaceuticals, which ranges between $600 million to $1.2 billion for 10-12 years. Therefore, the high cost of radiopharmaceuticals is likely to act as a major restraint for market growth.

Research collaborations and partnerships are gaining significant popularity in the radiopharmaceuticals market over recent years. Major companies operating in the radiopharmaceuticals market are collaborating with other industry players to conduct R&D activities to expand their business. For instance, in March 2020, Debiopharm, a Switzerland-based biopharmaceutical company, signed a research agreement with 3B Pharmaceuticals (3BP), a Germany-based biotechnology firm, to develop the Debio 0228 radioligand program, targeting CAIX (Carbonic Anhydrase 9) enzyme to fight the progression of cancer.

Many companies are adopting various strategic initiatives such as opening a new manufacturing facility and plant capacity expansion, which is gaining significant popularity in the radiopharmaceuticals market. For instance, in May 2019, ITM Isotopen Technologien Munchen AG (ITM) announced the launch of its new manufacturing facility in the Munich area to increase the production capacity of high-purity (n.c.a.) Lutetium-177 and no-carrier-added (n.c.a.) Lutetium-177 containing radiopharmaceuticals. Lutetium-177 is popular under brand EndolucinBeta and is an innovative isotope used in cancer therapy. This is the company’s step towards meeting the high demand for quality medical isotopes for precision oncology worldwide.

The increasing prevalence of cancer and cardiovascular diseases is projected to drive the demand for the radiopharmaceuticals market. Radiopharmaceuticals are emerging as a safe and effective therapeutic option over conventional medicines. Radiopharmaceuticals provide an upper hand to radiologists to treat cancer and cardiovascular diseases due to their benefits such as targeted therapy. According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide with an estimate of 9.6 million deaths in 2018. Moreover, the number of new cancer cases in the USA is predicted to increase by 24% cases (1 million) in men and 21% cases (0.9 million) in women annually, between 2010 and 2020, according to the Centers for Disease Control and Prevention (CDC). Thus, the rising cases of cancer and cardiovascular diseases are expected to surge the demand for radiopharmaceuticals for the treatment of these diseases.
Note: Product cover images may vary from those shown
  • Siemens Healthcare Private Limited
  • Bayer
  • GE Healthcare
  • Novartis AG
  • Cardinal Health
  • Lantheus Medical Imaging Inc.
  • Bracco Imaging S.p.A.
  • Nordion Inc. (A Subsidiary of Sterigenics International)
  • Mallinckrodt plc
  • Curium
  • Eckert & Ziegler
  • Eli Lilly
  • Eckert & Ziegler
  • IBA Group
  • Merck & Co. Inc.
  • Philips Healthcare
  • Fujifilm Holding Corporation
  • Areva Pharma
  • Navidea Biopharmaceuticals Inc.
  • Actinium Pharmaceuticals Inc.
  • Global Medical Solutions LTD.
  • Shine Medical Technologies
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll